News
Hosted on MSN1mon
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays BullishNovo Holdings, the controlling shareholder of drug maker Novo Nordisk, said on Wednesday that its total income and investment return in 2024 nearly doubled to DKK 60 billion ($8.69 billion ...
It has controlling stakes in Novo Nordisk, in which it has 77% of voting shares, and Novonesis. In 2024, it invested 4.6 billion euros in life sciences targeting cancer, obesity, and ...
These questions have driven Professor Julia Vorholt's groundbreaking research work, which has now earned her the 2025 Novonesis Biotechnology Prize, awarded by the Novo Nordisk Foundation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback